Literature DB >> 6401608

Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).

C C Johnston, R D Altman, R E Canfield, G A Finerman, J D Taulbee, M L Ebert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401608

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  14 in total

Review 1.  Treatment of patients with Paget's disease of bone.

Authors:  C Roux; M Dougados
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  Adverse effects of bisphosphonates. A comparative review.

Authors:  S Adami; N Zamberlan
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

3.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 4.  Paget's disease of bone.

Authors:  C G Ooi; W D Fraser
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

5.  Short term high doses of etidronate in Paget's disease of bone.

Authors:  J A Kanis; R E Gray; S A Murray; N A Hamdy; G H Urwin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

Review 6.  Treating Paget's disease.

Authors:  D A Heath
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

7.  Monitoring the treatment of Paget's disease with etidronate.

Authors:  J A Kanis
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

Review 8.  Bisphosphonates in bone diseases.

Authors:  R W Sparidans; I M Twiss; S Talbot
Journal:  Pharm World Sci       Date:  1998-10

9.  Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate.

Authors:  M Audran; P Clochon; D Etghen; B Mazieres; J C Renier
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 10.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.